chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pruritus, Rash, Rash erythematous, Scab
Clinical narrative: She said she was itching all over, on her scalp, stomach, thighs and other areas; Little red bumps; She scratches until they become scabs.; She states she is not better.; She started to get a rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (She said she was itching all over, on her scalp, stomach, thighs and other areas), RASH ERYTHEMATOUS (Little red bumps), SCAB (She scratches until they become scabs.), MALAISE (She states she is not better.) and RASH (She started to get a rash) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20a and 023m20a) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced PRURITUS (She said she was itching all over, on her scalp, stomach, thighs and other areas), RASH ERYTHEMATOUS (Little red bumps), SCAB (She scratches until they become scabs.), MALAISE (She states she is not better.) and RASH (She started to get a rash). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (She said she was itching all over, on her scalp, stomach, thighs and other areas), RASH ERYTHEMATOUS (Little red bumps), SCAB (She scratches until they become scabs.), MALAISE (She states she is not better.) and RASH (She started to get a rash) outcome was unknown.            concomitant medications include blood pressure medication. Treatment medication included some cream. Patient states she consulted a dermatologist then saw her PCP that had an intern. Patient states she had a whole house purification system and sent some water to the University thinking it had ferric in there but was high in sodium and might be affecting her blood pressure medication.  Patient has cut out bread, eggs, gluten and not sure what else the  patient can cut out.  Patient states that she is not getting the booster.   Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: Follow-up received contains No New Information.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: very bad had to go to the hospital; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (very bad had to go to the hospital) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (very bad had to go to the hospital). At the time of the report, VACCINATION COMPLICATION (very bad had to go to the hospital) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Inappropriate schedule of product administration
Clinical narrative: A little uncomfortable feeling after the first 2 doses; 2nd dose received more than 35 days apart from 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (A little uncomfortable feeling after the first 2 doses) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received more than 35 days apart from 1st dose) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included INFLIXIMAB (REMICADE) for Rheumatoid arthritis.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received more than 35 days apart from 1st dose). On an unknown date, the patient experienced FEELING ABNORMAL (A little uncomfortable feeling after the first 2 doses). On 16-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received more than 35 days apart from 1st dose) had resolved. At the time of the report, FEELING ABNORMAL (A little uncomfortable feeling after the first 2 doses) outcome was unknown.            No treatment medication was reported. No lab data was provided.   This case was linked to MOD-2021-378141 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity, Pyrexia
Clinical narrative: General soreness in my arm; Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (General soreness in my arm), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 602A21A and 022L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CELECOXIB (CELEBREX) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (General soreness in my arm), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (General soreness in my arm), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-378077, MOD-2021-378105 (Patient Link).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Blood blister, Depression
Clinical narrative: Blood blister in my hand/ Seemed like a blood clot; depressed; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD BLISTER (Blood blister in my hand/ Seemed like a blood clot) and DEPRESSION (depressed) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Nov-2021 at 1:00 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced BLOOD BLISTER (Blood blister in my hand/ Seemed like a blood clot) and DEPRESSION (depressed). At the time of the report, BLOOD BLISTER (Blood blister in my hand/ Seemed like a blood clot) and DEPRESSION (depressed) outcome was unknown.            Patient is unhappy and stated the life is damaged. Patient thought blood blister thing was going to bleed and went to different doctors and they said "cover it in case it bleeds" and said not to worry about  The patient  took picture of this thing, it's huge.  Patient had no doubts that Moderna vaccine caused the blister  No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-333559, MOD-2021-333582 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bone pain, Chills, Feeling abnormal
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt bad after second shot), ASTHENIA (Felt weak after second shot), BONE PAIN (her bones hurt for 2-3 days) and CHILLS (Chills after second shot) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 030K20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high (High blood pressure), Hypothyroidism and Hypercholesterolemia (High Cholesterol.).   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced FEELING ABNORMAL (Felt bad after second shot), ASTHENIA (Felt weak after second shot) and CHILLS (Chills after second shot). 26-Feb-2021, the patient experienced BONE PAIN (her bones hurt for 2-3 days). On 01-Mar-2021, FEELING ABNORMAL (Felt bad after second shot), ASTHENIA (Felt weak after second shot), BONE PAIN (her bones hurt for 2-3 days) and CHILLS (Chills after second shot) had resolved.            No concomitant medications reported. No treatment information was provided.   This case was linked to MOD-2021-378101 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Illness, Nausea, Pyrexia
Clinical narrative: Very sick; Nauseated; Fever for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very sick), NAUSEA (Nauseated) and PYREXIA (Fever for 3 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Very sick), NAUSEA (Nauseated) and PYREXIA (Fever for 3 days). At the time of the report, ILLNESS (Very sick) and NAUSEA (Nauseated) outcome was unknown and PYREXIA (Fever for 3 days) had resolved.            No relevant concomitant medications were reported. Treatment information was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Felt little worse than he did after recieving the first 2 doses of vaccine Moderna; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt little worse than he did after recieving the first 2 doses of vaccine Moderna) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Felt little worse than he did after recieving the first 2 doses of vaccine Moderna). At the time of the report, VACCINATION COMPLICATION (Felt little worse than he did after recieving the first 2 doses of vaccine Moderna) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product included Blood pressure medications.  No treatment was received.  Patient reported that, she felt little worse than he did (her husband) after receiving the first 2 doses of the Moderna vaccine.   This case was linked to MOD-2021-378121 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity, Pyrexia
Clinical narrative: general soreness in my arm; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (general soreness in my arm), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CELECOXIB (CELEBREX) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (general soreness in my arm), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (general soreness in my arm), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient had episodes of chills and a fever, the fever would break, then it came back. This occurred 3 times with the first dose of the vaccine. The patient also had ageneral soreness in her arm and a headache. She would consider this nothing unusual.   This case was linked to MOD-2021-378077, MOD-2021-378066, MOD-2021-378077 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: Tired for 1 or 2 days (dose 1 and 2)/very fatigued for 1 or 2 days (dose 1 and 2); nausea for 2-3 days after second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of FATIGUE (Tired for 1 or 2 days (dose 1 and 2)/very fatigued for 1 or 2 days (dose 1 and 2)) and NAUSEA (nausea for 2-3 days after second dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0018(B)21A and 006M20A) for COVID-19 vaccination.     Concomitant products included ACYCLOVIR [ACICLOVIR] and OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired for 1 or 2 days (dose 1 and 2)/very fatigued for 1 or 2 days (dose 1 and 2)) and NAUSEA (nausea for 2-3 days after second dose). At the time of the report, FATIGUE (Tired for 1 or 2 days (dose 1 and 2)/very fatigued for 1 or 2 days (dose 1 and 2)) and NAUSEA (nausea for 2-3 days after second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included  supplements.   This case was linked to MOD-2021-378065, MOD-2021-378118 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Eye pain, Feeding disorder
Clinical narrative: Eyes sore; Stomach pain; sore arm; sweating; diarrhea; gagging; didn't eat for four days; nausea / terrible nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), RETCHING (gagging), FEEDING DISORDER (didn't eat for four days), HYPERHIDROSIS (sweating) and EYE PAIN (Eyes sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032F21A, 024M20A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hay fever and Stenosis (Stenosis in back). Concomitant products included NAPROXEN for Stenosis, LISINOPRIL, LEVOTHYROXINE SODIUM (SYNTHROID) and OMEPRAZOLE for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021 at 11:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced DIARRHOEA (diarrhea), RETCHING (gagging), FEEDING DISORDER (didn't eat for four days), NAUSEA (nausea / terrible nausea) and CHILLS (chills). On 05-Nov-2021, the patient experienced HYPERHIDROSIS (sweating). On an unknown date, the patient experienced EYE PAIN (Eyes sore), ABDOMINAL PAIN UPPER (Stomach pain) and MYALGIA (sore arm). The patient was treated with ATROPINE SULFATE, DIPHENOXYLATE HYDROCHLORIDE (LOMOTIL [ATROPINE SULFATE;DIPHENOXYLATE HYDROCHLORIDE]) from 05-Nov-2021 to 06-Nov-2021 for Diarrhea, at an unspecified dose and frequency; ONDANSETRON (ZOFRAN [ONDANSETRON]) on 05-Nov-2021 for Nausea, at an unspecified dose and frequency; PROMETHAZINE HYDROCHLORIDE (PHENERGAN ELIXIR) on 07-Nov-2021 for Stomach pain, at an unspecified dose and frequency and ELECTROLYTES NOS, GLUCOSE (PEDIALYTE [ELECTROLYTES NOS;GLUCOSE]) for Dehydration, at an unspecified dose and frequency. On 06-Nov-2021, DIARRHOEA (diarrhea) and HYPERHIDROSIS (sweating) had resolved. At the time of the report, RETCHING (gagging) and ABDOMINAL PAIN UPPER (Stomach pain) had not resolved, FEEDING DISORDER (didn't eat for four days), EYE PAIN (Eyes sore), MYALGIA (sore arm) and CHILLS (chills) outcome was unknown and NAUSEA (nausea / terrible nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications also included OTC for allergy/hay fever.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Myalgia, Nausea, Retching
Clinical narrative: Eyes sore; Stomach pain; sore arm; sweating; diarrhea; gagging; didn't eat for four days; nausea / terrible nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), RETCHING (gagging), FEEDING DISORDER (didn't eat for four days), HYPERHIDROSIS (sweating) and EYE PAIN (Eyes sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032F21A, 024M20A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hay fever and Stenosis (Stenosis in back). Concomitant products included NAPROXEN for Stenosis, LISINOPRIL, LEVOTHYROXINE SODIUM (SYNTHROID) and OMEPRAZOLE for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021 at 11:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced DIARRHOEA (diarrhea), RETCHING (gagging), FEEDING DISORDER (didn't eat for four days), NAUSEA (nausea / terrible nausea) and CHILLS (chills). On 05-Nov-2021, the patient experienced HYPERHIDROSIS (sweating). On an unknown date, the patient experienced EYE PAIN (Eyes sore), ABDOMINAL PAIN UPPER (Stomach pain) and MYALGIA (sore arm). The patient was treated with ATROPINE SULFATE, DIPHENOXYLATE HYDROCHLORIDE (LOMOTIL [ATROPINE SULFATE;DIPHENOXYLATE HYDROCHLORIDE]) from 05-Nov-2021 to 06-Nov-2021 for Diarrhea, at an unspecified dose and frequency; ONDANSETRON (ZOFRAN [ONDANSETRON]) on 05-Nov-2021 for Nausea, at an unspecified dose and frequency; PROMETHAZINE HYDROCHLORIDE (PHENERGAN ELIXIR) on 07-Nov-2021 for Stomach pain, at an unspecified dose and frequency and ELECTROLYTES NOS, GLUCOSE (PEDIALYTE [ELECTROLYTES NOS;GLUCOSE]) for Dehydration, at an unspecified dose and frequency. On 06-Nov-2021, DIARRHOEA (diarrhea) and HYPERHIDROSIS (sweating) had resolved. At the time of the report, RETCHING (gagging) and ABDOMINAL PAIN UPPER (Stomach pain) had not resolved, FEEDING DISORDER (didn't eat for four days), EYE PAIN (Eyes sore), MYALGIA (sore arm) and CHILLS (chills) outcome was unknown and NAUSEA (nausea / terrible nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications also included OTC for allergy/hay fever.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination complication
Clinical narrative: Felt little worse than he did; 2nd dose received more than 35 days apart from 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt little worse than he did) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received more than 35 days apart from 1st dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received more than 35 days apart from 1st dose). On an unknown date, the patient experienced VACCINATION COMPLICATION (Felt little worse than he did). On 16-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received more than 35 days apart from 1st dose) had resolved. At the time of the report, VACCINATION COMPLICATION (Felt little worse than he did) outcome was unknown.            Concomitant medications also included basic blood pressure medications. No treatment was received.  Patient reported that she felt little worse than he did after receiving the first 2 doses of the Moderna vaccine   This case was linked to MOD-2021-378102 (Patient Link).
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Paranasal sinus discomfort, Pyrexia, Tinnitus
Clinical narrative: Mild Vertigo; Ringing in ears; Sinus pressure; Headache; Mild headache; Little fever; First dose on 19-jan-2021 and second dose on 18-mar-2021; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Mild Vertigo), TINNITUS (Ringing in ears), PARANASAL SINUS DISCOMFORT (Sinus pressure), HEADACHE (Mild headache) and PYREXIA (Little fever) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0021321A and 13L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Bladder cancer.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 19-jan-2021 and second dose on 18-mar-2021). On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Mild headache) and PYREXIA (Little fever). In April 2021, the patient experienced VERTIGO (Mild Vertigo), TINNITUS (Ringing in ears), PARANASAL SINUS DISCOMFORT (Sinus pressure) and HEADACHE (Headache). On 18-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 19-jan-2021 and second dose on 18-mar-2021) had resolved. At the time of the report, VERTIGO (Mild Vertigo), TINNITUS (Ringing in ears), PARANASAL SINUS DISCOMFORT (Sinus pressure), HEADACHE (Mild headache), PYREXIA (Little fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Acoustic stimulation tests: negative (Negative) negative. On an unknown date, Computerised tomogram: negative (Negative) negative.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-385189 (Patient Link).
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Mild Vertigo; Ringing in ears; Sinus pressure; Headache; Mild headache; Little fever; First dose on 19-jan-2021 and second dose on 18-mar-2021; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Mild Vertigo), TINNITUS (Ringing in ears), PARANASAL SINUS DISCOMFORT (Sinus pressure), HEADACHE (Mild headache) and PYREXIA (Little fever) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0021321A and 13L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Bladder cancer.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 19-jan-2021 and second dose on 18-mar-2021). On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Mild headache) and PYREXIA (Little fever). In April 2021, the patient experienced VERTIGO (Mild Vertigo), TINNITUS (Ringing in ears), PARANASAL SINUS DISCOMFORT (Sinus pressure) and HEADACHE (Headache). On 18-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 19-jan-2021 and second dose on 18-mar-2021) had resolved. At the time of the report, VERTIGO (Mild Vertigo), TINNITUS (Ringing in ears), PARANASAL SINUS DISCOMFORT (Sinus pressure), HEADACHE (Mild headache), PYREXIA (Little fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Acoustic stimulation tests: negative (Negative) negative. On an unknown date, Computerised tomogram: negative (Negative) negative.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-385189 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Limb discomfort, Somnolence, Vaccination site discomfort
Clinical narrative: arm discomfort; sleepiness; heaviness; pain in the arm; redness in the arm; swelling in the arm; headache; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (arm discomfort), SOMNOLENCE (sleepiness), LIMB DISCOMFORT (heaviness), VACCINATION SITE PAIN (pain in the arm) and VACCINATION SITE ERYTHEMA (redness in the arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOMFORT (arm discomfort), SOMNOLENCE (sleepiness), LIMB DISCOMFORT (heaviness), VACCINATION SITE PAIN (pain in the arm), VACCINATION SITE ERYTHEMA (redness in the arm), VACCINATION SITE SWELLING (swelling in the arm), HEADACHE (headache) and FATIGUE (tiredness). The patient was treated with PARACETAMOL (PANADOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOMFORT (arm discomfort), SOMNOLENCE (sleepiness), LIMB DISCOMFORT (heaviness), VACCINATION SITE PAIN (pain in the arm), VACCINATION SITE ERYTHEMA (redness in the arm), VACCINATION SITE SWELLING (swelling in the arm), HEADACHE (headache) and FATIGUE (tiredness) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-378001 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: arm discomfort; sleepiness; heaviness; pain in the arm; redness in the arm; swelling in the arm; headache; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (arm discomfort), SOMNOLENCE (sleepiness), LIMB DISCOMFORT (heaviness), VACCINATION SITE PAIN (pain in the arm) and VACCINATION SITE ERYTHEMA (redness in the arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOMFORT (arm discomfort), SOMNOLENCE (sleepiness), LIMB DISCOMFORT (heaviness), VACCINATION SITE PAIN (pain in the arm), VACCINATION SITE ERYTHEMA (redness in the arm), VACCINATION SITE SWELLING (swelling in the arm), HEADACHE (headache) and FATIGUE (tiredness). The patient was treated with PARACETAMOL (PANADOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOMFORT (arm discomfort), SOMNOLENCE (sleepiness), LIMB DISCOMFORT (heaviness), VACCINATION SITE PAIN (pain in the arm), VACCINATION SITE ERYTHEMA (redness in the arm), VACCINATION SITE SWELLING (swelling in the arm), HEADACHE (headache) and FATIGUE (tiredness) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-378001 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: full dose given for booster; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL OVERDOSE (full dose given for booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (full dose given for booster). At the time of the report, ACCIDENTAL OVERDOSE (full dose given for booster) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: A little uncomfortable feeling after the first 2 doses; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (A little uncomfortable feeling after the first 2 doses) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included INFLIXIMAB (REMICADE) for Rheumatoid arthritis.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (A little uncomfortable feeling after the first 2 doses). At the time of the report, FEELING ABNORMAL (A little uncomfortable feeling after the first 2 doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment drug details was reported. Had rheumatoid arthritis and has been on Remicade even before receiving the first dose of the moderna vaccine.  Consumer stated that on 9-Nov-2021 the patient had an infusion for rheumatoid arthritis of Remicade for 2 hours.   This case was linked to MOD-2021-378050 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: Received a booster dose of 0.5ml; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (Received a booster dose of 0.5ml) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A, 028L-20A and 028L-20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced ACCIDENTAL OVERDOSE (Received a booster dose of 0.5ml). On 05-Nov-2021, ACCIDENTAL OVERDOSE (Received a booster dose of 0.5ml) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided.Treatment information was not provided. The booster dose should be 0.25 ml, but stated that a patient who received a booster dose of 0.5ml.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on trunk , back and Neck 2 days after first shot; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on trunk , back and Neck 2 days after first shot) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on trunk , back and Neck 2 days after first shot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (Rash on trunk , back and Neck 2 days after first shot) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications was reported.   This case was linked to MOD-2021-378000 (Patient Link).   Reporter did not allow further contact
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Visual impairment
Clinical narrative: Has started with impairment in eyes; Booster dose made it worst; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (Has started with impairment in eyes) and CONDITION AGGRAVATED (Booster dose made it worst) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 077C21B) for COVID-19 vaccination.     The patient's past medical history included Eye disorder NOS (Degradation in eyes). Concurrent medical conditions included Thyroid disorder NOS and Blood pressure high. Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VISUAL IMPAIRMENT (Has started with impairment in eyes) and CONDITION AGGRAVATED (Booster dose made it worst). At the time of the report, VISUAL IMPAIRMENT (Has started with impairment in eyes) and CONDITION AGGRAVATED (Booster dose made it worst) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications include Blood pressure medicine and Thyroid medicine No treatment medications were reported
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Runny nose two days ago/sniffles; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose two days ago/sniffles) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (Runny nose two days ago/sniffles). At the time of the report, RHINORRHOEA (Runny nose two days ago/sniffles) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Accidental exposure to product
Clinical narrative: An employee was administering a dose of the Moderna Covid-19 vaccine & the syringe came apart & vaccine splashed in employee's eye.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL EXPOSURE TO PRODUCT (An employee was administering a dose of the Moderna Covid-19 vaccine & the syringe came apart & vaccine splashed in employee's eye.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT (An employee was administering a dose of the Moderna Covid-19 vaccine & the syringe came apart & vaccine splashed in employee's eye.). On 08-Nov-2021, ACCIDENTAL EXPOSURE TO PRODUCT (An employee was administering a dose of the Moderna Covid-19 vaccine & the syringe came apart & vaccine splashed in employee's eye.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not provided. Treatment details were not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Chest pain, Cough, Headache, Inappropriate schedule of product administration
Clinical narrative: Patient was not feeling well; Cough; Sore throat; Runny nose; Chest burning; Like the flu; Nausea; Headache; Sleepy; Was all day in bed; Low fever; Possible wrong vaccine schedule; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy), BEDRIDDEN (Was all day in bed), MALAISE (Patient was not feeling well), COUGH (Cough) and OROPHARYNGEAL PAIN (Sore throat) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression, Blood pressure high, Heart disease, unspecified and Urinary infection.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Possible wrong vaccine schedule). On 07-Apr-2021, the patient experienced SOMNOLENCE (Sleepy), BEDRIDDEN (Was all day in bed) and PYREXIA (Low fever). On an unknown date, the patient experienced MALAISE (Patient was not feeling well), COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), CHEST PAIN (Chest burning), INFLUENZA LIKE ILLNESS (Like the flu), NAUSEA (Nausea) and HEADACHE (Headache). On 04-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Possible wrong vaccine schedule) had resolved. On 08-Apr-2021, SOMNOLENCE (Sleepy), BEDRIDDEN (Was all day in bed) and PYREXIA (Low fever) had resolved. At the time of the report, MALAISE (Patient was not feeling well), COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), CHEST PAIN (Chest burning), INFLUENZA LIKE ILLNESS (Like the flu), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications includes unspecified drugs for depression, cholesterol, high blood pressure, something for the heart and chronic urine infection. Current condition also included Cholesterol. No Treatment information was reported.   This case was linked to MOD-2021-378173 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Malaise, Nausea, Oropharyngeal pain, Pyrexia
Clinical narrative: Patient was not feeling well; Cough; Sore throat; Runny nose; Chest burning; Like the flu; Nausea; Headache; Sleepy; Was all day in bed; Low fever; Possible wrong vaccine schedule; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy), BEDRIDDEN (Was all day in bed), MALAISE (Patient was not feeling well), COUGH (Cough) and OROPHARYNGEAL PAIN (Sore throat) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression, Blood pressure high, Heart disease, unspecified and Urinary infection.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Possible wrong vaccine schedule). On 07-Apr-2021, the patient experienced SOMNOLENCE (Sleepy), BEDRIDDEN (Was all day in bed) and PYREXIA (Low fever). On an unknown date, the patient experienced MALAISE (Patient was not feeling well), COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), CHEST PAIN (Chest burning), INFLUENZA LIKE ILLNESS (Like the flu), NAUSEA (Nausea) and HEADACHE (Headache). On 04-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Possible wrong vaccine schedule) had resolved. On 08-Apr-2021, SOMNOLENCE (Sleepy), BEDRIDDEN (Was all day in bed) and PYREXIA (Low fever) had resolved. At the time of the report, MALAISE (Patient was not feeling well), COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), CHEST PAIN (Chest burning), INFLUENZA LIKE ILLNESS (Like the flu), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications includes unspecified drugs for depression, cholesterol, high blood pressure, something for the heart and chronic urine infection. Current condition also included Cholesterol. No Treatment information was reported.   This case was linked to MOD-2021-378173 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Somnolence
Clinical narrative: Patient was not feeling well; Cough; Sore throat; Runny nose; Chest burning; Like the flu; Nausea; Headache; Sleepy; Was all day in bed; Low fever; Possible wrong vaccine schedule; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy), BEDRIDDEN (Was all day in bed), MALAISE (Patient was not feeling well), COUGH (Cough) and OROPHARYNGEAL PAIN (Sore throat) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression, Blood pressure high, Heart disease, unspecified and Urinary infection.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Possible wrong vaccine schedule). On 07-Apr-2021, the patient experienced SOMNOLENCE (Sleepy), BEDRIDDEN (Was all day in bed) and PYREXIA (Low fever). On an unknown date, the patient experienced MALAISE (Patient was not feeling well), COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), CHEST PAIN (Chest burning), INFLUENZA LIKE ILLNESS (Like the flu), NAUSEA (Nausea) and HEADACHE (Headache). On 04-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Possible wrong vaccine schedule) had resolved. On 08-Apr-2021, SOMNOLENCE (Sleepy), BEDRIDDEN (Was all day in bed) and PYREXIA (Low fever) had resolved. At the time of the report, MALAISE (Patient was not feeling well), COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), CHEST PAIN (Chest burning), INFLUENZA LIKE ILLNESS (Like the flu), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications includes unspecified drugs for depression, cholesterol, high blood pressure, something for the heart and chronic urine infection. Current condition also included Cholesterol. No Treatment information was reported.   This case was linked to MOD-2021-378173 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: feeling abnormal; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling abnormal) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (feeling abnormal). At the time of the report, FEELING ABNORMAL (feeling abnormal) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided No treatment medication provided   This case was linked to MOD-2021-378200, MOD-2021-378201 (Patient Link).